Pneumococcal Vaccines Adoption Market - Forecast(2024 - 2030)
Pneumococcal Vaccines Adoption Market Overview
Pneumococcal Vaccines Adoption Market size is estimated at $8.2 billion in 2020, projected to grow at a CAGR of 6.8% during the forecast period 2021-2026. Pneumococcal disease is the infection caused by pneumococcal bacteria (primarily Streptococcus pneumonia). The types of Pneumococcal Vaccines are Pneumococcal Conjugate Vaccines (PCV) and Pneumococcal Polysaccharide Vaccines (PPSV). The growth of the Pneumococcal Vaccines Adoption Industry owes towards the increasing prevalence of pneumococcal contaminations. Pneumococcal polysaccharide vaccine, also known as Pneumovax 23, was the first pneumococcal vaccine made from a capsular polysaccharide and is a major medical achievement. Pneumococcal survival is improved when pentafluorobenzoic acid (PFBA) inhibits neutrophil phagocytosis. These bacteria are capable of causing a number of illnesses, including pneumonia, which is a lung infection. Pneumonia is an acute respiratory illness that affects the lungs and causes the alveoli to fill with pus and fluid, making breathing difficult and limiting oxygen intake. The increasing prevalence of pneumonia in different countries around the world, strengthened healthcare facilities, and increased government emphasis on pneumonia immunization programs has resulted in an increase in demand for Pneumococcal Polysaccharide Vaccine. According to the World Health Organization (WHO), pneumonia caused 16% of all deaths in children under the age of five in 2015, accounting for 920,136 deaths worldwide driving the Pneumococcal Vaccines Adoption industry growth.
Report Coverage
Key Takeaways
- The easier access to healthcare facilities and the availability of low-cost pneumonia vaccines have attracted a significant number of buyers, resulting in Pneumococcal Vaccines Adoption Market’s growth.
- Geographically, North America Pneumococcal Vaccines Adoption Market held the largest revenue share of 42% in 2020 owing to the growing number of pneumococcal infections, the involvement of potential players who are developing innovative therapies, and more government schemes and investments in healthcare. In the final report, the scope of the Pneumococcal Polysaccharide Vaccine Market for various regions will be given.
- The increased prevalence rate of pneumonia is driving the development are likely to contribute to the growth of the Pneumococcal Vaccines Adoption industry.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market is provided in the Pneumococcal Vaccines Adoption Market.
Pneumococcal Vaccines Adoption Market Segment Analysis - By Type
Pneumococcal Vaccines Adoption Market Segment Analysis – By Product Type
Pneumococcal Vaccines Adoption Market Segment Analysis - By Geography
Pneumococcal Vaccines Adoption Market: Market Share (%) by Region, 2020
Pneumococcal Vaccines Adoption Market Drivers
Growing Incidences Of Pneumococcal Diseases:
The Creation Of Protein Vaccines Pave The Way For New Possibilities:
Pneumococcal Vaccines Adoption Market Challenges
Stringent Regulation Along With Lack Of Storage Facilities:
Pneumococcal Vaccines Adoption Market Landscape
Acquisitions/Product Launches:
- In December 2020, Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved a Biologics License Application (BLA) for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate for the prevention of invasive disease and pneumonia triggered by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 and older for priority examination.
- In June 2020, Merck & Co., Inc. acquired Themis is a privately owned company that focuses on infectious disease vaccines and immunomodulation therapies. The purchase was made to promote the production of medicines and vaccines for many of the world's most complex diseases, as part of our effort to save and improve lives.
Related Reports-
For more Lifesciences and Healthcare Market reports, Please click here
LIST OF TABLES
1.Global Competition Analysis Market 2023-2030 ($M)2.Global Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 ($M)
2.1 Pneumococcal Conjugate Vaccines Market 2023-2030 ($M) - Global Industry Research
2.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 ($M) - Global Industry Research
2.3 By Product Type, Market 2023-2030 ($M) - Global Industry Research
3.Global Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
3.1 Pharmacies Market 2023-2030 ($M) - Global Industry Research
3.2 Community Clinics Market 2023-2030 ($M) - Global Industry Research
3.3 Public Health Agencies Market 2023-2030 ($M) - Global Industry Research
3.4 By Distribution Channel, Market 2023-2030 ($M) - Global Industry Research
4.Global Competition Analysis Market 2023-2030 (Volume/Units)
5.Global Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 (Volume/Units)
5.1 Pneumococcal Conjugate Vaccines Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 By Product Type, Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 (Volume/Units)
6.1 Pharmacies Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Community Clinics Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Public Health Agencies Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 By Distribution Channel, Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Competition Analysis Market 2023-2030 ($M)
8.North America Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 ($M)
8.1 Pneumococcal Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
8.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 ($M) - Regional Industry Research
8.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
9.North America Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
9.1 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
9.2 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
9.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
9.4 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
10.South America Competition Analysis Market 2023-2030 ($M)
11.South America Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 ($M)
11.1 Pneumococcal Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
11.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 ($M) - Regional Industry Research
11.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
12.South America Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
12.1 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
12.2 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
12.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
12.4 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
13.Europe Competition Analysis Market 2023-2030 ($M)
14.Europe Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 ($M)
14.1 Pneumococcal Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
14.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 ($M) - Regional Industry Research
14.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
15.Europe Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
15.1 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
15.2 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
15.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
15.4 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
16.APAC Competition Analysis Market 2023-2030 ($M)
17.APAC Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 ($M)
17.1 Pneumococcal Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
17.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 ($M) - Regional Industry Research
17.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
18.APAC Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
18.1 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
18.2 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
18.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
18.4 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
19.MENA Competition Analysis Market 2023-2030 ($M)
20.MENA Pneumococcal Vaccines Market Analysis and Forecast , By Product Market 2023-2030 ($M)
20.1 Pneumococcal Conjugate Vaccines Market 2023-2030 ($M) - Regional Industry Research
20.2 Pneumococcal Polysaccharide Vaccines Market 2023-2030 ($M) - Regional Industry Research
20.3 By Product Type, Market 2023-2030 ($M) - Regional Industry Research
21.MENA Pneumococcal Vaccines Market Analysis and Forecast , By Distribution Channel Market 2023-2030 ($M)
21.1 Pharmacies Market 2023-2030 ($M) - Regional Industry Research
21.2 Community Clinics Market 2023-2030 ($M) - Regional Industry Research
21.3 Public Health Agencies Market 2023-2030 ($M) - Regional Industry Research
21.4 By Distribution Channel, Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)2.Canada Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
3.Mexico Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
4.Brazil Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
5.Argentina Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
6.Peru Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
7.Colombia Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
8.Chile Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
9.Rest of South America Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
10.UK Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
11.Germany Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
12.France Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
13.Italy Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
14.Spain Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
15.Rest of Europe Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
16.China Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
17.India Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
18.Japan Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
19.South Korea Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
20.South Africa Pneumococcal Vaccines Adoption Trends 2019 Market Revenue, 2023-2030 ($M)
21.North America Pneumococcal Vaccines Adoption Trends 2019 By Application
22.South America Pneumococcal Vaccines Adoption Trends 2019 By Application
23.Europe Pneumococcal Vaccines Adoption Trends 2019 By Application
24.APAC Pneumococcal Vaccines Adoption Trends 2019 By Application
25.MENA Pneumococcal Vaccines Adoption Trends 2019 By Application